Broncus Holding's total inventories for the quarter that ended in Dec. 2025 was $3.87 Mil. Broncus Holding's average total inventories from the quarter that ended in Jun. 2025 to the quarter that ended in Dec. 2025 was $3.66 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Broncus Holding's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was $0.23.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Broncus Holding's Days Inventory for the
six
months ended in Dec. 2025 was 1,023.59.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Broncus Holding's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.18.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Broncus Holding (OTCPK:BRNHF) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Broncus Holding's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Broncus Holding's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Broncus Holding Total Inventories Related Terms
Broncus Holding Total Inventories Historical Data
* Premium members only.
The historical data trend for Broncus Holding's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Broncus Holding (BRNHF) has a Total Inventories of $3.87 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Broncus Holding and its competitors.
Is Broncus Holding's Total Inventories too high?
Broncus Holding's current Total Inventories is $3.87 Mil. Overall, Broncus Holding has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Broncus Holding's Total Inventories compare to ABT and SYK?
Broncus Holding's Total Inventories of $3.87 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Medical Devices & Instruments company?
A good Total Inventories depends on the Medical Devices & Instruments industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Broncus Holding and its competitors. Broncus Holding's current Total Inventories is $3.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Broncus Holding stock overvalued right now?
Broncus Holding (BRNHF) has a current Total Inventories of $3.87 Mil. The current Total Inventories is $3.87 Mil. Broncus Holding's overall GF Score™ is 39/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Broncus Holding (BRNHF), the current Total Inventories is $3.87 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD. Geographically, the company operates in Chinese Mainland; European Union; and Other Regions.
39GF Score
Get the complete analysis for BRNHF
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRNHF has been successfully added to your 
